Looming competition from the east
29/11/19 -"A number of initiatives taken by the Chinese government to strengthen its pharmaceutical sector have started to bear fruit – Biogene’s ‘zanubrutinib’ became the first innovative drug by a Chinese ..."
Pages
90
Language
English
Published on
29/11/19
You may also be interested by these reports :
03/07/20
With CHF13bn ($14bn) annual sales, Roche is a dominant force in the global diagnostics market. Interestingly, in recent years, most diagnostics ...
03/07/20
With increasing demand for Roche’s COVID-19 tests – particularly molecular tests, the annual top-line should benefit by CHF1.5bn. Moreover, taking ...
29/06/20
As many people have been either staying indoors or wearing masks outdoors, there has been a reduction in pollen allergies, which in turn has put ...
26/06/20
Sanofi is developing a COVID-19 vaccine based on the traditional/proven recombinant-platform technology. It has the capability to manufacture 1bn ...